Clinical Trial Update: Dose-adjusted EPOCH-R in MYC Positive DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 trial of dose-adjusted EPOCH-R for MYC-positive diffuse large B-cell lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: TERMINATED